InflaRx N.V. (IFRX) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference - Slideshow

InflaRx N.V. presented at the Oppenheimer 36th Annual Healthcare Life Sciences Conference in February 2026, showcasing its latest corporate and clinical updates through a slide deck. The presentation likely focused on the company’s pipeline of complement system inhibitors, particularly its lead drug candidates targeting inflammatory and autoimmune diseases. Key highlights may include clinical trial progress, regulatory milestones, or strategic partnerships, though specific details were not disclosed in the transcript summary. The event provided investors and analysts with insights into InflaRx’s financial health, R&D priorities, and market positioning within the biopharmaceutical sector. Seeking Alpha’s transcripts team published the slide deck as part of its ongoing coverage of earnings calls and industry conferences, expanding access to corporate disclosures.